Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamas Pharmaceuticals
Adamas Pharmaceuticals
(ADMS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Microcrystalline cellulose
lymphoma
,
hiv
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
plasmablastic lymphoma
,
large-cell lymphoma immunoblastic
,
healthy volunteers/patients
,
breast neoplasms
,
postmenopause
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
hiv infections
,
acquired immunodeficiency syndrome
,
immunologic deficiency syndromes
,
infections
,
hiv-1
,
communicable diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
contraception
,
heart failure
,
systolic heart failure
,
systolic murmurs
,
obesity
,
neoplasms
Potassium magnesium citrate (4:1:2)
lymphoma
,
hiv
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
plasmablastic lymphoma
,
large-cell lymphoma immunoblastic
,
healthy volunteers/patients
,
breast neoplasms
,
postmenopause
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
hiv infections
,
acquired immunodeficiency syndrome
,
immunologic deficiency syndromes
,
infections
,
hiv-1
,
communicable diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
contraception
,
heart failure
,
systolic heart failure
,
systolic murmurs
,
neoplasms
Fluzone
neoplasms
Potassium nitrate
lymphoma
,
hiv
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
plasmablastic lymphoma
,
large-cell lymphoma immunoblastic
,
healthy volunteers/patients
,
breast neoplasms
,
postmenopause
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
hiv infections
,
acquired immunodeficiency syndrome
,
immunologic deficiency syndromes
,
infections
,
hiv-1
,
communicable diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
contraception
,
heart failure
,
systolic heart failure
,
systolic murmurs
,
neoplasms
Flumist
neoplasms
Flucelvax
neoplasms
Isoxaflutole
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
sickle cell anemia
,
erectile dysfunction
,
systemic lupus erythematosus
,
psoriatic arthritis
,
arthritis
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
urinary bladder neoplasms
,
uterine neoplasms
,
liver neoplasms
,
kidney neoplasms
,
uterine cervical neoplasms
,
colonic neoplasms
,
hematologic diseases
,
hematopoietic stem cell transplantation
,
bone marrow transplantation
,
acromegaly
,
cardiovascular diseases
,
rare diseases
,
oncogenes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use